Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Inflammatory Bowel Diseases

Free Subscription Articles published in Am J Gastroenterol Retrieve available abstracts of 243 articles: HTML format

Single Articles

July 2026
1. CONSTANT BD, Feng Y, Huang J, Okraku-Mantey J, et al
   The Safety and Effectiveness of Early Anti-Tumor-Necrosis-Factor Therapy for Penetrating Crohn's Disease Complications in Children.
   Am J Gastroenterol. 2026 Jul 1. doi: 10.14309/ajg.0000000000004104.
   PubMed     Abstract available
   
   
   June 2026
2. CHODEN T, Mathew AJ, Goffinet A, Scott A, et al
   Impact of Upadacitinib on Cardiovascular Events and Lipid Values in Older Inflammatory Bowel Disease Patients with Baseline Cardiovascular Risk.
   Am J Gastroenterol. 2026 Jun 9. doi: 10.14309/ajg.0000000000004074.
   PubMed     Abstract available
   
   
   
3. SLEIMAN J, Pillai GV, Chirra P, Gandhi NS, et al
   Development of a Computed Tomography Enterography Based Radiomics Model to Characterize Inflammation, Fibrosis and Smooth Muscle Thickening in Stricturing Crohn's Disease.
   Am J Gastroenterol. 2026 Jun 9. doi: 10.14309/ajg.0000000000004073.
   PubMed     Abstract available
   
   
   
4. CALDERA F, Farraye FA
   Guidelines in Practice: Preventive Care in Inflammatory Bowel Disease.
   Am J Gastroenterol. 2026 Jun 8. doi: 10.14309/ajg.0000000000004070.
   PubMed    
   
   
   
5. TSE CS, Lewis JD, Horst SN, Saha S, et al
   Inflammatory Bowel Diseases-Specific Cognitive Behavioral Therapy Delivered Through Telehealth Reduces Disability: Addressing Disability Effectively With Psychosocial Telemedicine Pragmatic Randomized Controlled Trial.
   Am J Gastroenterol. 2026;121:1435-1444.
   PubMed     Abstract available
   
   
   May 2026
6. AXELRAD JE, Faye A, Siegel CA
   Communicating Risk and Safety of Inflammatory Bowel Disease Therapies.
   Am J Gastroenterol. 2026 May 27. doi: 10.14309/ajg.0000000000004068.
   PubMed     Abstract available
   
   
   
7. CALDERA F, Hayney MS, Strople JA, Kastl AJ, et al
   High Rates of Seroprotection for Measles in Pediatric Patients with Inflammatory Bowel Disease.
   Am J Gastroenterol. 2026 May 20. doi: 10.14309/ajg.0000000000004050.
   PubMed     Abstract available
   
   
   
8. BORREN NZ, Paulides E, Klaassen MAY, Alm E, et al
   Microbiome-Directed Therapy for Fatigue in Quiescent Inflammatory Bowel Disease: A Randomized Placebo-Controlled Trial of Multi-Strain Probiotic Supplementation.
   Am J Gastroenterol. 2026 May 19. doi: 10.14309/ajg.0000000000004056.
   PubMed     Abstract available
   
   
   
9. CHOI D, Sheridan H, Choden T
   Primer: Understanding Medicare for Advanced Therapies for Inflammatory Bowel Disease.
   Am J Gastroenterol. 2026 May 5. doi: 10.14309/ajg.0000000000004042.
   PubMed    
   
   
   
10. LOFTUS EV JR, Joshi N, Sands BE, Jairath V, et al
    Improvement in Health-Related Quality of Life in Patients With Moderate to Severe Crohn's Disease Treated With Risankizumab Versus Ustekinumab in the Phase 3B SEQUENCE Study.
    Am J Gastroenterol. 2026 May 5. doi: 10.14309/ajg.0000000000004044.
    PubMed     Abstract available
    
    
    
11. LICHTENSTEIN GR, Allegretti JR, Rubin DT, Magro F, et al
    Efficacy and Safety of Guselkumab for Ulcerative Colitis Through Week 92 of the QUASAR Long-Term Extension Study.
    Am J Gastroenterol. 2026 May 1. doi: 10.14309/ajg.0000000000004041.
    PubMed     Abstract available
    
    
    April 2026
12. GOODWIN SW, Vuyyuru SK, Sedano R, Zou G, et al
    An Enhanced Treatment Algorithm Targeting Mucosal Healing is Effective and Safe in Older Patients with Crohn's Disease: A Post-hoc Analysis of the REACT2 Trial.
    Am J Gastroenterol. 2026 Apr 3. doi: 10.14309/ajg.0000000000004015.
    PubMed     Abstract available
    
    
    
13. GROSS SA, Shaukat A, Afzali A, Ahn JC, et al
    Artificial Intelligence for Gastroenterology Practice: A Modified Delphi Consensus.
    Am J Gastroenterol. 2026;121:1017-1024.
    PubMed     Abstract available
    
    
    March 2026
14. BAKER NM, Santiago-Soltero K, Anshelevich E, Ebriani J, et al
    Identifying key predictors of metastatic cutaneous Crohn's disease: a case-control study.
    Am J Gastroenterol. 2026 Mar 20. doi: 10.14309/ajg.0000000000004003.
    PubMed     Abstract available
    
    
    
15. LIE M, Skjernaa SR, Klitgaard KMM, Michno HS, et al
    Phenotypic presentation of pediatric inflammatory bowel disease through 4 decades: The Pediatric NorDIBD cohort.
    Am J Gastroenterol. 2026 Mar 3. doi: 10.14309/ajg.0000000000003986.
    PubMed     Abstract available
    
    
    
16. CHAMBERS CD, Johnson DL, Luo Y, Xu R, et al
    Birth Outcomes in Women Who Have Taken Vedolizumab in Pregnancy: Results From the Vedolizumab Pregnancy Exposure Registry.
    Am J Gastroenterol. 2026;121:720-732.
    PubMed     Abstract available
    
    
    February 2026
17. BHAT S, Falaiye T, Moses J, Lukin DJ, et al
    The Costs of Inflammatory Bowel Disease and the Financial Impact of Insurance Delays.
    Am J Gastroenterol. 2026 Feb 27. doi: 10.14309/ajg.0000000000003975.
    PubMed     Abstract available
    
    
    
18. HARRIS HM, Ghoneim S, Kochar B, Casey K, et al
    Differences in Outcomes following Ileocecal Resection in Older Adults with Crohn's Disease in the Biologic Era.
    Am J Gastroenterol. 2026 Feb 25. doi: 10.14309/ajg.0000000000003978.
    PubMed     Abstract available
    
    
    
19. SCALDAFERRI F, Di Vincenzo F, Aloi M, Ascolani M, et al
    Multicenter Real-World Outcomes of Risankizumab in Crohn's Disease: The RESOLVE IG-IBD Study.
    Am J Gastroenterol. 2026 Feb 18. doi: 10.14309/ajg.0000000000003969.
    PubMed     Abstract available
    
    
    
20. KOCHAR B, Faye AS, Araka E, Glasser R, et al
    The bidirectional relationship between cognitive function and active inflammatory bowel disease.
    Am J Gastroenterol. 2026 Feb 13. doi: 10.14309/ajg.0000000000003965.
    PubMed     Abstract available
    
    
    
21. SHEEHAN JL, Clauw DJ, Singh P, Lee A, et al
    Nociplastic Pain is Associated with Increased Healthcare Utilization and Lower Quality of Life in Patients with Inflammatory Bowel Disease.
    Am J Gastroenterol. 2026 Feb 12. doi: 10.14309/ajg.0000000000003948.
    PubMed     Abstract available
    
    
    
22. ZURBUCH E, Mahadevan U, Shah S, Zhang X, et al
    Prior Abdominal Surgery is Not Associated with Adverse Pregnancy, Delivery or Neonatal Outcomes in Women with Crohn's Disease: Results from the Pregnancy in Inflammatory Bowel Disease and Neonatal Outcomes (PIANO) Study.
    Am J Gastroenterol. 2026 Feb 11. doi: 10.14309/ajg.0000000000003947.
    PubMed     Abstract available
    
    
    
23. YANOFSKY R, McDonald BD, Nikzad N, Choi D, et al
    Erratum to: New Eczematous Eruption in Patients With Inflammatory Bowel Disease Who Stop Janus Kinase Inhibitors.
    Am J Gastroenterol. 2026 Feb 5. doi: 10.14309/ajg.0000000000003937.
    PubMed    
    
    
    
24. WONG ECL, Jairath V, Dulai PS, Marshall JK, et al
    Infliximab and Upadacitinib Demonstrate Superior Early Onset of Efficacy in Biologic-Naive Ulcerative Colitis with Severe Endoscopic Disease.
    Am J Gastroenterol. 2026 Feb 2. doi: 10.14309/ajg.0000000000003940.
    PubMed     Abstract available
    
    
    
25. BENNETT A, Field J, Newman KL, Click B, et al
    Gender-Affirming Hormone Therapy and Risk of Inflammatory Bowel Disease Flare in Transgender and Gender Diverse Adults.
    Am J Gastroenterol. 2026;121:404-409.
    PubMed     Abstract available
    
    
    January 2026
26. BEDELL A, McDermott AR, Karpin JE, Rodriguez TG, et al
    Ethical and Practical Considerations for Mental Health Screening in Adult Patients with Inflammatory Bowel Disease.
    Am J Gastroenterol. 2026 Jan 22. doi: 10.14309/ajg.0000000000003927.
    PubMed     Abstract available
    
    
    
27. 
    Correction to: Clinical Evolution, Complications, and Need for Advanced Therapy in Patients With Ulcerative Colitis (Abstract S2018); Pioneering Minimally Invasive Management of Pancreatic Neuroendocrine Tumor: First EUS-RFA Case in Colombia (Abstract
    Am J Gastroenterol. 2026 Jan 22. doi: 10.14309/ajg.0000000000003893.
    PubMed    
    
    
    
28. TARIQ R, Sethi A, Arunachalam S, Pardi DS, et al
    Machine Learning Model Predicts Recurrent Clostridioides difficile Infection in Patients With Inflammatory Bowel Disease (Recur CDI-IBD).
    Am J Gastroenterol. 2026 Jan 21. doi: 10.14309/ajg.0000000000003922.
    PubMed     Abstract available
    
    
    
29. REINISCH W, Atreya R, Rieder F, Jairath V, et al
    Clinical Trial Endpoints for Perianal Fistulizing Crohn's Disease.
    Am J Gastroenterol. 2026 Jan 8. doi: 10.14309/ajg.0000000000003906.
    PubMed     Abstract available
    
    
    
30. MOUTSOGLOU D
    Continuing Medical Education Questions: January 2026.
    Am J Gastroenterol. 2026;121:29.
    PubMed     Abstract available
    
    
    
31. HOFFERT Y, Wang Z, Fumery M, Nachury M, et al
    A Risk Stratification Tool for Relapse After Intravenous-To-Subcutaneous Switching of Infliximab in Patients With Inflammatory Bowel Diseases.
    Am J Gastroenterol. 2026;121:179-186.
    PubMed     Abstract available
    
    
    
32. FRIEDMAN S, Nielsen J, Andersen ML, Norgard BM, et al
    Complications of Ileus and Bowel Obstruction During Pregnancy in Women Who Have Had Surgery for Inflammatory Bowel Disease: A Population-Based Study.
    Am J Gastroenterol. 2026;121:187-194.
    PubMed     Abstract available
    
    
    
33. MOUTSOGLOU D
    Continuing Medical Education Questions: January 2026.
    Am J Gastroenterol. 2026;121:29.
    PubMed     Abstract available
    
    
    December 2025
34. VAVRICKA SR, Zeitz J, Madanchi M, Ruiz PA, et al
    A PROSPECTIVE INTERVENTIONAL STUDY TO EVALUATE THE EFFECT OF HYPOXIA ON HEALTHY VOLUNTEERS AND PATIENTS WITH INFLAMMATORY BOWEL DISEASE: THE ALTITUDE IBD STUDY.
    Am J Gastroenterol. 2025 Dec 16. doi: 10.14309/ajg.0000000000003888.
    PubMed     Abstract available
    
    
    
35. RUBIN DT, Ananthakrishnan AN, Siegel CA, Barnes EL, et al
    Correction: ACG Clinical Guideline Ulcerative Colitis in Adults.
    Am J Gastroenterol. 2025 Dec 15. doi: 10.14309/ajg.0000000000003828.
    PubMed    
    
    
    
36. MESQUITA P, Ponte A, Lage J, Cardoso J, et al
    When Refractory Crohn's Disease Isn't Crohn's: Ileal Endometriosis.
    Am J Gastroenterol. 2025 Dec 12. doi: 10.14309/ajg.0000000000003882.
    PubMed    
    
    
    November 2025
37. WINDSOR JW, Coward S, Hracs L, Mak JWY, et al
    TRENDS IN THE ULCERATIVE COLITIS TO CROHN'S DISEASE INCIDENCE RATIO ARE DISTINCT BETWEEN EPIDEMIOLOGIC STAGES OF INFLAMMATORY BOWEL DISEASE.
    Am J Gastroenterol. 2025 Nov 24. doi: 10.14309/ajg.0000000000003868.
    PubMed     Abstract available
    
    
    
38. DUBINSKY M, Bleakman AP, Vavricka S, Travis S, et al
    Bowel Urgency in Crohn's Disease: Bridging the Gap Between Patients and Healthcare Providers.
    Am J Gastroenterol. 2025 Nov 19. doi: 10.14309/ajg.0000000000003858.
    PubMed     Abstract available
    
    
    
39. ARAKA E, Kahn-Boesel O, Lopes E, Ufere NN, et al
    Women and Younger Adults with Inflammatory Bowel Disease are at Greater Risk for Financial Toxicity from IBD.
    Am J Gastroenterol. 2025 Nov 18. doi: 10.14309/ajg.0000000000003847.
    PubMed     Abstract available
    
    
    
40. STIDHAM RW, Cai L, Wittrup E, Rice M, et al
    Artificial Intelligence Analysis of Endoscopy Outperforms Conventional Endoscopic Scoring for Agreement with Symptoms and Quality of Life in a Phase 3 Ulcerative Colitis Trial.
    Am J Gastroenterol. 2025 Nov 17. doi: 10.14309/ajg.0000000000003838.
    PubMed     Abstract available
    
    
    
41. TARIQ R
    Redefining Success in Inflammatory Bowel Disease Beyond Inflammation: Time to Aim Higher!
    Am J Gastroenterol. 2025 Nov 14. doi: 10.14309/ajg.0000000000003793.
    PubMed    
    
    
    
42. RAO BB
    Continuing Medical Education Questions: November 2025.
    Am J Gastroenterol. 2025;120:2484.
    PubMed     Abstract available
    
    
    
43. YARUR AJ, Long MD, Torres J, Nandi N, et al
    Body Mass Index Did Not Affect Efficacy and Safety of Etrasimod: A Post Hoc Analysis of the ELEVATE Ulcerative Colitis Clinical Program.
    Am J Gastroenterol. 2025;120:2611-2622.
    PubMed     Abstract available
    
    
    
44. RAO BB
    Continuing Medical Education Questions: November 2025.
    Am J Gastroenterol. 2025;120:2484.
    PubMed     Abstract available
    
    
    October 2025
45. CALDERA F, Hayney MS, Strople JA, Kastl AJ, et al
    Low Sensitivity of Commercial Assays for Varicella Zoster Virus Seropositivity in Pediatric Patients with Inflammatory Bowel Disease.
    Am J Gastroenterol. 2025 Oct 28. doi: 10.14309/ajg.0000000000003819.
    PubMed     Abstract available
    
    
    
46. PARIGI TL, Nardone OM, Lisa M, Massimino L, et al
    The impact of E-Cigarettes and Heat-Not-Burn Tobacco on Postoperative Recurrence of Crohn's Disease: A Multicenter International Study.
    Am J Gastroenterol. 2025 Oct 24. doi: 10.14309/ajg.0000000000003810.
    PubMed     Abstract available
    
    
    
47. CLARKE LM, Hsu S, Pant D, James K, et al
    The Risk of Hypertensive Disorders of Pregnancy in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2025 Oct 23. doi: 10.14309/ajg.0000000000003818.
    PubMed     Abstract available
    
    
    
48. AHUJA D, Dziegielewski C, Yeh KH, Patel SB, et al
    Comparative Safety of Advanced Therapies in Patients with Ulcerative Colitis: An Administrative Claims-based Study.
    Am J Gastroenterol. 2025 Oct 22. doi: 10.14309/ajg.0000000000003806.
    PubMed     Abstract available
    
    
    
49. WU HY, Yang CY, Weng MT, Tung CC, et al
    Demodicosis Mimics Acneiform Eruptions in Patients with Inflammatory Bowel Disease Receiving Upadacitinib: A Case Series.
    Am J Gastroenterol. 2025 Oct 22. doi: 10.14309/ajg.0000000000003813.
    PubMed     Abstract available
    
    
    
50. GHONEIM S, Choe H, Boneschansker L, Sachdeva K, et al
    Delayed Remission With Advanced Therapies Is Not Associated With Worse One-Year Outcomes In Inflammatory Bowel Disease.
    Am J Gastroenterol. 2025 Oct 13. doi: 10.14309/ajg.0000000000003795.
    PubMed     Abstract available
    
    
    
51. KOCHAR B, Katz S, Faye AS
    Practical Advice for the Management of Older Adults With Inflammatory Bowel Disease.
    Am J Gastroenterol. 2025;120.
    PubMed    
    
    
    
52. HUAN PW, Mehta A, Wong ECL, Dulai PS, et al
    A Review of the Modified Multiplier of Simple Endoscopic Score for Crohn's Disease and How to Use It in Clinical Trials and Practice.
    Am J Gastroenterol. 2025;120:2242-2250.
    PubMed     Abstract available
    
    
    
53. PARK Y MD, Park JH DDS, Leem GH, Song TJ MD, et al
    Periodontitis and the Incidence of Inflammatory Bowel Diseases: A Nationwide Population-Based Cohort Study.
    Am J Gastroenterol. 2025;120:2361-2372.
    PubMed     Abstract available
    
    
    
54. SANDS BE, Rubin DT, Loftus EV Jr, Wolf DC, et al
    Impact of Prior Biologic Exposure on Ozanimod Efficacy and Safety in the Phase 3 True North Clinical Trial.
    Am J Gastroenterol. 2025;120:2339-2349.
    PubMed     Abstract available
    
    
    September 2025
55. RD L, Tc J, F Z, Y H, et al
    Gut microbiota are more strongly associated with impairments in health-related quality of life than disease activity in inflammatory bowel disease.
    Am J Gastroenterol. 2025 Sep 29. doi: 10.14309/ajg.0000000000003773.
    PubMed     Abstract available
    
    
    
56. PAL P, Mateen MA, Pooja K, Marri UK, et al
    Correlation and assessment of small bowel lesions using cross sectional imaging techniques compared to small intestinal contrast ultrasonography in known Crohn's disease (the CACTUS-CD study): a paired, prospective, confirmatory study.
    Am J Gastroenterol. 2025 Sep 29. doi: 10.14309/ajg.0000000000003776.
    PubMed     Abstract available
    
    
    
57. KURT G, Troelsen FS, Veres K, Sorensen HT, et al
    Risk of venous thromboembolism following colorectal cancer surgery in patients with and without inflammatory bowel disease.
    Am J Gastroenterol. 2025 Sep 3. doi: 10.14309/ajg.0000000000003761.
    PubMed     Abstract available
    
    
    August 2025
58. ANDRE M, Kirchgesner J, Laharie D, Guillo L, et al
    Sub-cutaneous infliximab for perianal Crohn's disease: the BioLap-Rem multicentre study from the GETAID.
    Am J Gastroenterol. 2025 Aug 28. doi: 10.14309/ajg.0000000000003755.
    PubMed     Abstract available
    
    
    
59. MAHADEVAN U, Seow CH, Barnes EL, Chaparro M, et al
    Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2025 Aug 27. doi: 10.14309/ajg.0000000000003651.
    PubMed     Abstract available
    
    
    
60. YANOFSKY R, McDonald BD, Nikzad N, Choi D, et al
    New Eczematous Eruption in Patients with Inflammatory Bowel Disease Who Stop Janus Kinase Inhibitors.
    Am J Gastroenterol. 2025 Aug 22. doi: 10.14309/ajg.0000000000003742.
    PubMed     Abstract available
    
    
    
61. ANTAYA M, Hudson AS, Lerner EP, Nasser K, et al
    The impact of integrating pelvic MRI at diagnosis on early detection of perianal Crohn's disease in pediatrics.
    Am J Gastroenterol. 2025 Aug 20. doi: 10.14309/ajg.0000000000003733.
    PubMed     Abstract available
    
    
    
62. ZHANG Q, Liu H, Liu S, Zhu S, et al
    Increased mortality associated with sarcopenia in inflammatory bowel disease: a long-term prospective cohort study.
    Am J Gastroenterol. 2025 Aug 20. doi: 10.14309/ajg.0000000000003734.
    PubMed     Abstract available
    
    
    
63. NARULA N, Wong ECL, Mente A, Rangarajan S, et al
    Ultra-Processed Grains and Risk of Inflammatory Bowel Disease: Results from the Prospective Urban Rural Epidemiology (PURE) Study.
    Am J Gastroenterol. 2025 Aug 4. doi: 10.14309/ajg.0000000000003700.
    PubMed     Abstract available
    
    
    
64. BORRAS-BLASCO J, Valcuende-Rosique A, Cornejo-Uixeda S
    Persistence, Effectiveness, and Safety of Upadacitinib in Crohn's Disease and Ulcerative Colitis in Real Life: Results From a Spanish Nationwide Study (Ureal Study).
    Am J Gastroenterol. 2025 Aug 4. doi: 10.14309/ajg.0000000000003619.
    PubMed    
    
    
    
65. KOCHAR B, Sun J, Olen O, Halfvarson J, et al
    Inflammatory bowel disease patients are at increased risk for interstitial lung diseases.
    Am J Gastroenterol. 2025 Aug 4. doi: 10.14309/ajg.0000000000003699.
    PubMed     Abstract available
    
    
    July 2025
66. EBERT AC, Verstockt B, Bogsted M, Larsen L, et al
    Inflammatory bowel disease and risk of more than 1500 comorbidities: A disease-wide pre- and post-diagnostic phenomic association study.
    Am J Gastroenterol. 2025 Jul 30. doi: 10.14309/ajg.0000000000003673.
    PubMed     Abstract available
    
    
    
67. DEZA DC, Dominguez CL, Oliver AP, Cuadro CP, et al
    The Patients Included in Clinical Trials of Biological Drugs for Inflammatory Bowel Disease Do Not Represent the Real-World Population.
    Am J Gastroenterol. 2025 Jul 30. doi: 10.14309/ajg.0000000000003670.
    PubMed     Abstract available
    
    
    
68. NGUYEN NV, Sandstrom A, Dominicus A, Mageau A, et al
    Thiopurines and intrahepatic cholestasis of pregnancy in systemic lupus erythematosus and inflammatory bowel disease pregnancies.
    Am J Gastroenterol. 2025 Jul 23. doi: 10.14309/ajg.0000000000003652.
    PubMed     Abstract available
    
    
    
69. ZHENG J, Huang P, Feng R, Li L, et al
    Early Improvement of Mental Health is Associated with Long-term Disease Remission in Ulcerative Colitis.
    Am J Gastroenterol. 2025 Jul 7. doi: 10.14309/ajg.0000000000003638.
    PubMed     Abstract available
    
    
    
70. KOJIMA K, Takada J, Shimizu M
    Asymptomatic Yersinia Colitis Mimicking Neoplasia in Ulcerative Colitis.
    Am J Gastroenterol. 2025 Jul 2. doi: 10.14309/ajg.0000000000003626.
    PubMed    
    
    
    
71. FARRAYE FA, Melmed GY, Lichtenstein GR, Barnes EL, et al
    ACG Clinical Guideline Update: Preventive Care in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2025;120:1447-1473.
    PubMed     Abstract available
    
    
    June 2025
72. BARNES EL, Raffals L, Qazi T, Deepak P, et al
    A Prospective Comparison of Ustekinumab and Anti-TNF Therapy in the Treatment of Crohn's-like Disease of the Pouch.
    Am J Gastroenterol. 2025 Jun 25. doi: 10.14309/ajg.0000000000003608.
    PubMed     Abstract available
    
    
    
73. MEYER A, Carbonnel F, Dahm CC, Halkjaer J, et al
    Fruits, vegetables, legumes and potatoes and risk of Crohn's disease and ulcerative colitis.
    Am J Gastroenterol. 2025 Jun 24. doi: 10.14309/ajg.0000000000003602.
    PubMed     Abstract available
    
    
    
74. SALEH H, Horst S, Kinnucan J
    Dissatisfaction and Barriers in Electronic Health Record Use for Inflammatory Bowel Disease Patients: A Nationwide Survey of Major IBD Centers.
    Am J Gastroenterol. 2025 Jun 16. doi: 10.14309/ajg.0000000000003598.
    PubMed     Abstract available
    
    
    
75. GAIDOS JKJ, Hashash JG
    Monitoring Inflammatory Bowel Disease Activity: When, How and Why.
    Am J Gastroenterol. 2025 Jun 9. doi: 10.14309/ajg.0000000000003582.
    PubMed     Abstract available
    
    
    
76. SOLITANO V, Ogunsakin RE, Yuan Y, Bernstein CN, et al
    Effectiveness and Safety of Advanced Combination Treatment (ACT) in patients with refractory inflammatory bowel disease or concomitant immune mediated disease or extra-intestinal manifestations: A Multi-Center Canadian Study.
    Am J Gastroenterol. 2025 Jun 5. doi: 10.14309/ajg.0000000000003573.
    PubMed     Abstract available
    
    
    
77. LICHTENSTEIN GR, Loftus EV, Afzali A, Long MD, et al
    ACG Clinical Guideline: Management of Crohn's Disease in Adults.
    Am J Gastroenterol. 2025;120:1225-1264.
    PubMed     Abstract available
    
    
    
78. RUBIN DT, Ananthakrishnan AN, Siegel CA, Barnes EL, et al
    ACG Clinical Guideline Update: Ulcerative Colitis in Adults.
    Am J Gastroenterol. 2025;120:1187-1224.
    PubMed     Abstract available
    
    
    
79. SHUKLA AP
    Continuing Medical Education Questions: June 2025.
    Am J Gastroenterol. 2025;120:1186.
    PubMed     Abstract available
    
    
    
80. SHUJA A
    Continuing Medical Education Questions: June 2025.
    Am J Gastroenterol. 2025;120:1185.
    PubMed     Abstract available
    
    
    May 2025
81. PAL P
    Listening Beyond the Symptoms: Existential Needs and Identity in Older Adults With Inflammatory Bowel Disease.
    Am J Gastroenterol. 2025 May 27. doi: 10.14309/ajg.0000000000003514.
    PubMed    
    
    
    
82. DUGGAL S, Mahapatra S, Garrison K, Robles A, et al
    Assessing Gastrointestinal Awareness on TikTok: A Content Analysis of Colorectal Cancer, IBS, and IBD Narratives.
    Am J Gastroenterol. 2025 May 14. doi: 10.14309/ajg.0000000000003539.
    PubMed     Abstract available
    
    
    
83. CHESTER MA, Keefer L
    Beyond Depression and Anxiety in Inflammatory Bowel Diseases: Forging a Path Toward Emotional Healing.
    Am J Gastroenterol. 2025;120:999-1006.
    PubMed     Abstract available
    
    
    
84. ADLER J, Galanko JA, Ammoury R, Benkov KJ, et al
    HLA DQA1*05 and Risk of Antitumor Necrosis Factor Treatment Failure and Anti-Drug Antibody Development in Children With Crohn's Disease.
    Am J Gastroenterol. 2025;120:1076-1086.
    PubMed     Abstract available
    
    
    April 2025
85. KOCHHAR GS, Dziegielewski C, Schairer JN, Cross RK, et al
    Role of Endoscopy in Inflammatory Bowel Disease: What Every Gastroenterologist Should Know.
    Am J Gastroenterol. 2025 Apr 29. doi: 10.14309/ajg.0000000000003507.
    PubMed     Abstract available
    
    
    
86. OHNO M, Nishida A, Yokota Y, Imai T, et al
    Early Stage Crohn's Disease-Associated Small Bowel Adenocarcinoma at Ileal Stenosis Detected by Ballon-Assisted Enteroscopy.
    Am J Gastroenterol. 2025 Apr 10. doi: 10.14309/ajg.0000000000003484.
    PubMed    
    
    
    
87. MELMED GY, Oliver B, Kennedy A, Hou JK, et al
    LONG-TERM SUSTAINED IMPROVEMENT IN UNPLANNED HEALTHCARE UTILIZATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE.
    Am J Gastroenterol. 2025 Apr 7. doi: 10.14309/ajg.0000000000003454.
    PubMed     Abstract available
    
    
    
88. RUSHER A, Fuss A, Araka E, Cauley C, et al
    Existential Reflections by Older Adults With Inflammatory Bowel Diseases on Medical and Surgical Treatments.
    Am J Gastroenterol. 2025;120:1829-1838.
    PubMed     Abstract available
    
    
    
89. SEGURA A, Brensinger C, Pate V, Siddique SM, et al
    Association of Race and Ethnicity with Healthcare Utilization for Inflammatory Bowel Disease in the United States: A Retrospective Cohort Study.
    Am J Gastroenterol. 2025 Apr 1. doi: 10.14309/ajg.0000000000003438.
    PubMed     Abstract available
    
    
    
90. DRITTEL D, Schreiber-Stainthorp W, Delau O, Gurunathan SV, et al
    Severe Polypharmacy Increases Risk of Hospitalization Among Older Adults With Inflammatory Bowel Disease.
    Am J Gastroenterol. 2025;120:844-855.
    PubMed     Abstract available
    
    
    March 2025
91. KAYAL M
    A Practical Guide to the Use of Guselkumab for Moderate-Severe Ulcerative Colitis.
    Am J Gastroenterol. 2025 Mar 31. doi: 10.14309/ajg.0000000000003446.
    PubMed    
    
    
    
92. DUNLEAVY K, Pedersen K, Cima R, Chedid V, et al
    Ileal pouch adenocarcinoma in a young patient with newly diagnosed Crohn's-like disease of the pouch.
    Am J Gastroenterol. 2025 Mar 26. doi: 10.14309/ajg.0000000000003426.
    PubMed    
    
    
    
93. CALDERA F, Hayney MS, Farraye FA, Fischer M, et al
    Low incidence of Varicella in Pediatric Patients with Inflammatory Bowel Disease.
    Am J Gastroenterol. 2025 Mar 18. doi: 10.14309/ajg.0000000000003418.
    PubMed     Abstract available
    
    
    
94. TORRES J, Panes J, Siegel CA, Dubinsky MC, et al
    Symptom Resolution and Meaningful Improvement in Quality of Life With Risankizumab in Patients With Ulcerative Colitis: Post Hoc Analysis of the Randomized INSPIRE and COMMAND Studies.
    Am J Gastroenterol. 2025 Mar 17. doi: 10.14309/ajg.0000000000003420.
    PubMed     Abstract available
    
    
    
95. LEE SD, Vermeire S, Ungaro R, Vadhariya A, et al
    Mirikizumab Improves Quality of Life and Work Productivity in Patients with Moderately to Severely Active Crohn's Disease: Results from the Phase 3 VIVID-1 study.
    Am J Gastroenterol. 2025 Mar 13. doi: 10.14309/ajg.0000000000003410.
    PubMed     Abstract available
    
    
    
96. LEE SD, Ehrlich AC, Pellanda P, Kaiser C, et al
    Long-Term Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis: An Integrated 2-Year Safety Analysis.
    Am J Gastroenterol. 2025 Mar 12. doi: 10.14309/ajg.0000000000003407.
    PubMed     Abstract available
    
    
    
97. DZIEGIELEWSKI C, Yuan Y, Ma C, Boland BS, et al
    IL-23p19 Antagonists vs. Ustekinumab for Treatment of Crohn's Disease: A Meta-analysis of Randomized Controlled Trials.
    Am J Gastroenterol. 2025 Mar 12. doi: 10.14309/ajg.0000000000003406.
    PubMed     Abstract available
    
    
    
98. YANG JC, Janssen EM, Wallace MJ, Sheahan A, et al
    Quantifying Patient Preferences for Risk Tolerance With Novel Dual Biologic Therapies for Inflammatory Bowel Disease.
    Am J Gastroenterol. 2025 Mar 6. doi: 10.14309/ajg.0000000000003397.
    PubMed     Abstract available
    
    
    
99. GOODWIN SW, Wilk P, Yuan Y, Haan M, et al
    Increasing rate of hospitalization for inflammatory bowel disease is an age-related effect: A Canadian Population Study.
    Am J Gastroenterol. 2025 Mar 4. doi: 10.14309/ajg.0000000000003385.
    PubMed     Abstract available
    
    
    February 2025
100. LO B, Moller B, Igel C, Wildt S, et al
     Improving the Real-time Classification of Disease Severity in Ulcerative Colitis: Artificial Intelligence as the Trigger for a Second Opinion.
     Am J Gastroenterol. 2025 Feb 28. doi: 10.14309/ajg.0000000000003382.
     PubMed     Abstract available
     
     
     
101. FU CJ, Chen HW, Wei JC
     Spine and Sacroiliac Joint Involvement in Newly Diagnosed Patients With Inflammatory Bowel Disease: Clinical and MRI Findings From a Population-Based Cohort.
     Am J Gastroenterol. 2025 Feb 25. doi: 10.14309/ajg.0000000000003340.
     PubMed    
     
     
     
102. NORGARD BM, Thorarinsson CT, Nielsen J, Dalal RS, et al
     Predictors for chronic opioid use in patients with inflammatory bowel disease - a population based cohort study.
     Am J Gastroenterol. 2025 Feb 5. doi: 10.14309/ajg.0000000000003353.
     PubMed     Abstract available
     
     
     
103. CALAFAT M, Suria C, Mesonero F, de Francisco R, et al
     HIV Infection Is Associated With a Less Aggressive Phenotype of Inflammatory Bowel Disease: A Multicenter Study of the ENEIDA Registry.
     Am J Gastroenterol. 2025;120:431-439.
     PubMed     Abstract available
     
     
     
104. SYSTROM HK, Rai V, Singh S, Baidoo L, et al
     When Perfect Is the Enemy of Good: Results of a RAND Appropriateness Panel on Treat to Target in Asymptomatic Inflammatory Bowel Disease.
     Am J Gastroenterol. 2025;120:420-430.
     PubMed     Abstract available
     
     
     
105. SHAH ND
     Continuing Medical Education Questions: February 2025.
     Am J Gastroenterol. 2025;120:289.
     PubMed     Abstract available
     
     
     January 2025
106. STEINSBO O, Aasprong OG, Aabakken L, Karlsen LN, et al
     Fecal Calprotectin Correlates with Disease Extent but Remains a Reliable Marker of Mucosal Healing in Ulcerative Colitis.
     Am J Gastroenterol. 2025 Jan 30. doi: 10.14309/ajg.0000000000003339.
     PubMed     Abstract available
     
     
     
107. OLIVERA PA, Parks ML, Zubiaurre I, Peyrin-Biroulet L, et al
     Comparative Improvement in Health-Related Quality of Life with Advanced Therapies for Moderate-to-Severe Crohn's Disease: A Network Meta-Analysis.
     Am J Gastroenterol. 2025 Jan 29. doi: 10.14309/ajg.0000000000003333.
     PubMed     Abstract available
     
     
     
108. MARILD K, Soderling J, Stephansson O, Axelrad J, et al
     Inflammatory Bowel Disease, Periconceptional Disease Activity, and Risk of Major Congenital Anomalies: A Nationwide Cohort Study.
     Am J Gastroenterol. 2025 Jan 8. doi: 10.14309/ajg.0000000000003306.
     PubMed     Abstract available
     
     
     
109. MEMEL Z, Yu A, Fenton C, Wen T, et al
     The Effect of Low-dose Aspirin on Disease Activity in Pregnant Individuals with Inflammatory Bowel Disease.
     Am J Gastroenterol. 2025 Jan 7. doi: 10.14309/ajg.0000000000003304.
     PubMed     Abstract available
     
     
     
110. HONG SJ, Dalal RS, Kuhn KA, Stahly A, et al
     Prevalence and Risk Factors of Spondyloarthritis Symptoms in a US-Based Multicenter Cohort of Patients with Inflammatory Bowel Disease.
     Am J Gastroenterol. 2025 Jan 6. doi: 10.14309/ajg.0000000000003292.
     PubMed     Abstract available
     
     
     
111. GIORDANO A, Perez-Martinez I, Gisbert JP, Ricart E, et al
     Ileal Predominance in Crohn's Disease Is Associated With Increased Intestinal Surgery and Biological Therapy Use, With Lower Treatment Persistence.
     Am J Gastroenterol. 2025;120:194-203.
     PubMed     Abstract available
     
     
     
112. SYAL G, Barnes E, Raffals L, Al Kazzi E, et al
     Medical Therapies for Prevention and Treatment of Inflammatory Pouch Disorders-A Systematic Review and Meta-Analysis.
     Am J Gastroenterol. 2025;120:135-150.
     PubMed     Abstract available
     
     
     December 2024
113. ALLEGRETTI JR, Cheifetz AS, Dulai PS, Stevens AC, et al
     SAFETY, PHARMACOKINETICS, AND CLINICAL EFFICACY OF ADS051, A NEUTROPHIL MODULATOR, IN ULCERATIVE COLITIS: RESULTS OF A RANDOMIZED PHASE 1B TRIAL.
     Am J Gastroenterol. 2024 Dec 31. doi: 10.14309/ajg.0000000000003269.
     PubMed     Abstract available
     
     
     
114. TANDON P, Huang V, Feig DS, Saskin R, et al
     Health-Care Utilization of Children Born to Women with and Without Inflammatory Bowel Disease in the First Five Years of Life: A Population-Cohort Study.
     Am J Gastroenterol. 2024 Dec 31. doi: 10.14309/ajg.0000000000003280.
     PubMed     Abstract available
     
     
     
115. CHETWOOD JD, Paramsothy S, Leong RW
     Infliximab and adalimumab in the treatment of fistulizing Crohn's disease: a propensity score-matched analysis from the prospective Persistence Australian National IBD Cohort (PANIC4) study.
     Am J Gastroenterol. 2024 Dec 30. doi: 10.14309/ajg.0000000000003271.
     PubMed     Abstract available
     
     
     
116. RODRIGUEZ-LAGO I, Aguirre U, Cabriada JL, Ungaro RC, et al
     Increased medication utilization precedes incidentally diagnosed inflammatory bowel disease: a multicenter, case-control study.
     Am J Gastroenterol. 2024 Dec 30. doi: 10.14309/ajg.0000000000003275.
     PubMed     Abstract available
     
     
     
117. GAO Z, Qi J, Ye W
     Comment on "Gallstone Disease Is Associated With an Increased Risk of Inflammatory Bowel Disease: Results From 3 Prospective Cohort Studies".
     Am J Gastroenterol. 2024 Dec 10. doi: 10.14309/ajg.0000000000003186.
     PubMed    
     
     
     November 2024
118. GARCIA MJ, Brenes Y, Vicuna M, Bermejo F, et al
     PERSISTENCE, EFFECTIVENESS, AND SAFETY OF UPADACITINIB IN CROHN'S DISEASE AND ULCERATIVE COLITIS IN REAL LIFE: RESULTS FROM A SPANISH NATIONWIDE STUDY (UREAL STUDY): Upadacitinib for IBD.
     Am J Gastroenterol. 2024 Nov 26. doi: 10.14309/ajg.0000000000003243.
     PubMed     Abstract available
     
     
     
119. CHEIFETZ AS, Allegretti JR, Quintas M, Dixit B, et al
     Small-Molecule Neutrophil Modulator ADS051 is Safe and Well-Tolerated in a Phase 1 Single Ascending Dose Study.
     Am J Gastroenterol. 2024;120:1585-1592.
     PubMed     Abstract available
     
     
     
120. SOLITANO V, Narula N, Ma C, Nanayakkara A, et al
     Effectiveness of Ustekinumab for patients with moderate to severe Ulcerative Colitis: A Multi-Center Real-World Canadian Study.
     Am J Gastroenterol. 2024 Nov 14. doi: 10.14309/ajg.0000000000003212.
     PubMed     Abstract available
     
     
     
121. ANDERSON SR, Ayoub M, Coats S, McHenry S, et al
     Safety and Effectiveness of Glucagon-like Peptide-1 Receptor Agonists in Inflammatory Bowel Disease.
     Am J Gastroenterol. 2024 Nov 14. doi: 10.14309/ajg.0000000000003208.
     PubMed     Abstract available
     
     
     
122. TANG WZ, Li JZ, Liu TH
     Tofacitinib vs Biologics: Postoperative Concerns in Ulcerative Colitis Colectomies.
     Am J Gastroenterol. 2024 Nov 14. doi: 10.14309/ajg.0000000000003148.
     PubMed    
     
     
     
123. KAO D, Wong K, Jijon H, Moayyedi P, et al
     Preliminary results from a multicenter, randomized trial using fecal microbial transplantation to induce remission in patients with mild to moderate Crohn's disease.
     Am J Gastroenterol. 2024 Nov 12. doi: 10.14309/ajg.0000000000003196.
     PubMed     Abstract available
     
     
     October 2024
124. ISAACS KL, Sayed CJ
     Nonmalignant dermatologic disorders in Inflammatory Bowel Disease.
     Am J Gastroenterol. 2024 Oct 23. doi: 10.14309/ajg.0000000000003155.
     PubMed     Abstract available
     
     
     
125. DANPANICHKUL P, Duangsonk K, Ho AH, Laoveeravat P, et al
     Disproportionately Increasing Incidence of Inflammatory Bowel Disease in Females and the Elderly: An Update Analysis from the Global Burden of Disease Study 2021.
     Am J Gastroenterol. 2024 Oct 18. doi: 10.14309/ajg.0000000000003143.
     PubMed     Abstract available
     
     
     
126. ADLER J, Galanko JA, Ammoury R, Benkov KJ, et al
     HLA DQA1*05 and risk of anti-TNF treatment failure and anti-drug antibody development in children with Crohn's Disease: HLA DQA1*05 and Pediatric Crohn's Disease.
     Am J Gastroenterol. 2024 Oct 18. doi: 10.14309/ajg.0000000000003135.
     PubMed     Abstract available
     
     
     
127. KHAN N, Patel D, Sundararajan R
     Incidence of thiopurine induced severe myelosuppression in a nationwide cohort of inflammatory bowel disease patients.
     Am J Gastroenterol. 2024 Oct 18. doi: 10.14309/ajg.0000000000003141.
     PubMed     Abstract available
     
     
     
128. CHEN J, Zhai C, Pan H
     Focusing on the Key Factors in the Treatment of Pediatric Crohn's Disease: A Re-Examination of the Relationship Between Body Mass Index and Antitumor Necrosis Factor Treatment Response.
     Am J Gastroenterol. 2024 Oct 10. doi: 10.14309/ajg.0000000000003101.
     PubMed    
     
     
     
129. TEMIDO MJ, Honap S, Bursztejn AC, Portela F, et al
     Drug-Induced Acne in Inflammatory Bowel Disease: A Practical Guide for the Gastroenterologist.
     Am J Gastroenterol. 2024 Oct 9. doi: 10.14309/ajg.0000000000003119.
     PubMed     Abstract available
     
     
     
130. MI N, Yang M, Wei L, Nie P, et al
     Gallstone disease is associated with an increased risk of inflammatory bowel disease: results from three prospective cohort studies.
     Am J Gastroenterol. 2024 Oct 4. doi: 10.14309/ajg.0000000000003111.
     PubMed     Abstract available
     
     
     
131. ABREU MT, Kosinski LR
     Correction to: How Did It Get So Difficult to Care for Patients With Inflammatory Bowel Disease?
     Am J Gastroenterol. 2024 Oct 3. doi: 10.14309/ajg.0000000000003051.
     PubMed    
     
     
     September 2024
132. LIN CP, Kuo P, Wei JC
     Addressing Additional Limitations in the Study on Small Intestine Cancer Risk in Patients With Inflammatory Bowel Disease.
     Am J Gastroenterol. 2024 Sep 27. doi: 10.14309/ajg.0000000000003053.
     PubMed    
     
     
     
133. CHO Y, Choi EY, Choi A, Han JY, et al
     Anti-Tumor Necrosis Factor Therapy and the Risk of Gestational Diabetes in Pregnant Women with Inflammatory Bowel Disease.
     Am J Gastroenterol. 2024 Sep 24. doi: 10.14309/ajg.0000000000003100.
     PubMed     Abstract available
     
     
     
134. FALLOON K, Forney M, Husni ME, Feagan B, et al
     Diagnosis and Management of Inflammatory Bowel Disease Associated Spondyloarthritis.
     Am J Gastroenterol. 2024 Sep 23. doi: 10.14309/ajg.0000000000003092.
     PubMed     Abstract available
     
     
     
135. ISSOKSON K, Lee DY, Yarur AJ, Lewis JD, et al
     The Role of Diet in Inflammatory Bowel Disease Onset, Disease Management, and Surgical Optimization.
     Am J Gastroenterol. 2024 Sep 19. doi: 10.14309/ajg.0000000000003085.
     PubMed     Abstract available
     
     
     
136. VAUGHN BP, Khoruts A, Fischer M
     Diagnosis and management of Clostridioides difficile in inflammatory bowel disease.
     Am J Gastroenterol. 2024 Sep 4. doi: 10.14309/ajg.0000000000003076.
     PubMed     Abstract available
     
     
     
137. YANG JY, Lund JL, Funk MJ, Hudgens MG, et al
     Correction to: Utilization of Treat-to-Target Monitoring Colonoscopy After Treatment Initiation in the US-Based Study of a Prospective Adult Research Cohort With Inflammatory Bowel Disease.
     Am J Gastroenterol. 2024;119:1950.
     PubMed    
     
     
     August 2024
138. KAYAL M, Posner H, Jimenez D, Huang J, et al
     Endoscopic Response Reduces the Risk of Subsequent Pouchitis in Patients with Crohn's Disease Like Pouch Inflammation.
     Am J Gastroenterol. 2024 Aug 27. doi: 10.14309/ajg.0000000000003055.
     PubMed     Abstract available
     
     
     
139. VLADIMIROVA N, Moller J, Attauabi M, Madsen G, et al
     Spine and sacroiliac joint involvement in newly diagnosed inflammatory bowel disease patients - clinical and magnetic resonance imaging findings from a population-based cohort.
     Am J Gastroenterol. 2024 Aug 20. doi: 10.14309/ajg.0000000000003039.
     PubMed     Abstract available
     
     
     
140. NAUDE C, Skvarc D, Maunick B, Evans S, et al
     Acceptance & Commitment Therapy for Adults Living With Inflammatory Bowel Disease & Distress: A Randomized Controlled Trial.
     Am J Gastroenterol. 2024 Aug 20. doi: 10.14309/ajg.0000000000003032.
     PubMed     Abstract available
     
     
     
141. DAI C, Huang YH, Jiang M
     Comparative Risk of Serious Infection With Vedolizumab vs Anti-Tumor Necrosis Factors in Inflammatory Bowel Disease.
     Am J Gastroenterol. 2024 Aug 19. doi: 10.14309/ajg.0000000000002995.
     PubMed    
     
     
     
142. AHMED NS, Krawchuk S, Buhler KA, Solitano V, et al
     US National Estimates of Contemporary Mortality Rates in Patients with Ulcerative Colitis Undergoing Colectomy.
     Am J Gastroenterol. 2024 Aug 14. doi: 10.14309/ajg.0000000000003031.
     PubMed     Abstract available
     
     
     July 2024
143. GLEAVE A, Shah A, Tahir U, Blom JJ, et al
     Using Diet to Treat Inflammatory Bowel Disease: A Systematic Review.
     Am J Gastroenterol. 2024 Jul 26. doi: 10.14309/ajg.0000000000002973.
     PubMed     Abstract available
     
     
     
144. LEE JW, Woo D, Kim KO, Kim ES, et al
     Deep learning model using stool pictures for predicting endoscopic mucosal inflammation in patients with ulcerative colitis.
     Am J Gastroenterol. 2024 Jul 25. doi: 10.14309/ajg.0000000000002978.
     PubMed     Abstract available
     
     
     
145. ALSAKARNEH S, Ahmed M, Azim S, Hashash JG, et al
     Risk of Small Intestine Cancer in Inflammatory Bowel Disease: A Propensity-Matched Study from a Large Multi-Center Database in the United States.
     Am J Gastroenterol. 2024 Jul 25. doi: 10.14309/ajg.0000000000002984.
     PubMed     Abstract available
     
     
     
146. PINNUCK B, Lynch KD
     Mortality in Acute Severe Ulcerative Colitis - Still an Alarming and Real Complication in the Era of Advanced Therapies.
     Am J Gastroenterol. 2024 Jul 16. doi: 10.14309/ajg.0000000000002917.
     PubMed    
     
     
     
147. CALAFAT M, Suria C, Mesonero F, de Francisco R, et al
     HIV infection is associated with a less aggressive phenotype of inflammatory bowel disease. A multicenter study of the ENEIDA registry.
     Am J Gastroenterol. 2024 Jul 15. doi: 10.14309/ajg.0000000000002965.
     PubMed     Abstract available
     
     
     
148. SHAH RS, Hu JH, Bachour S, Joseph A, et al
     Histologic Activity from Neoterminal Ileal Biopsies in Patients with Crohn's Disease in Endoscopic Remission is Associated with Postoperative Recurrence.
     Am J Gastroenterol. 2024 Jul 15. doi: 10.14309/ajg.0000000000002963.
     PubMed     Abstract available
     
     
     
149. KARLQVIST S, Sachs MC, Eriksson C, Cao Y, et al
     Comparative risk of serious infection with vedolizumab vs anti-TNF in inflammatory bowel disease: results from nationwide Swedish registers.
     Am J Gastroenterol. 2024 Jul 12. doi: 10.14309/ajg.0000000000002961.
     PubMed     Abstract available
     
     
     
150. KOCHHAR GS, Khataniar H, Jairath V, Farraye FA, et al
     Comparative Effectiveness of Upadacitinib and Tofacitinib in Ulcerative Colitis: A U.S. Propensity-Matched Cohort Study.
     Am J Gastroenterol. 2024 Jul 5. doi: 10.14309/ajg.0000000000002947.
     PubMed     Abstract available
     
     
     
151. DEJONG N, Zhang X, Kappelman M
     Prevalence of Preceding and Follow-up Outpatient Care Surrounding Emergency Department Visits for Pediatric Inflammatory Bowel Disease: Identifying Opportunities for Quality Improvement.
     Am J Gastroenterol. 2024 Jul 5. doi: 10.14309/ajg.0000000000002936.
     PubMed     Abstract available
     
     
     
152. TANDON P, Huang V, Feig DS, Saskin R, et al
     Recent Immigrants With Inflammatory Bowel Disease Have Significant Healthcare Utilization From Preconception to Postpartum: A Population Cohort Study.
     Am J Gastroenterol. 2024;119:1346-1354.
     PubMed     Abstract available
     
     
     June 2024
153. MURTHY SK, Tandon P, Matthews P, Ahmed F, et al
     A Population-Based Matched Cohort Study of Digestive System Cancer Incidence and Mortality in Individuals With and Without Inflammatory Bowel Disease.
     Am J Gastroenterol. 2024 Jun 25. doi: 10.14309/ajg.0000000000002900.
     PubMed     Abstract available
     
     
     
154. BARNES EL, Desai A, Hashash JG, Farraye FA, et al
     The Natural History after Ileal Pouch-Anal Anastomosis for Ulcerative Colitis: A Population-Based Cohort Study from the United States.
     Am J Gastroenterol. 2024 Jun 18. doi: 10.14309/ajg.0000000000002891.
     PubMed     Abstract available
     
     
     
155. KATHURIA P, Higgins PDR, Berinstein JA
     Timing Is Everything: The Lifesaving Potential of Early Medical Therapy in Acute Severe Ulcerative Colitis.
     Am J Gastroenterol. 2024 Jun 12. doi: 10.14309/ajg.0000000000002867.
     PubMed    
     
     
     
156. CONSTANT BD, Long MD, Scott FI, Higgins PDR, et al
     Associated With Decreased Insurance Satisfaction and Adverse Clinical Outcomes: An Inflammatory Bowel Disease Partners Survey.
     Am J Gastroenterol. 2024 Jun 3. doi: 10.14309/ajg.0000000000002851.
     PubMed     Abstract available
     
     
     May 2024
157. NOURELDIN M, Van T, Cohen-Mekelburg S, Scott FI, et al
     Legalization of Cannabis Does Not Reduce Opioid Prescribing in Patients With Inflammatory Bowel Disease: A Difference-in-Difference Analysis.
     Am J Gastroenterol. 2024 May 21. doi: 10.14309/ajg.0000000000002834.
     PubMed     Abstract available
     
     
     
158. KARIME C, Black CN, Cortes P, Kwon JY, et al
     Utility of a Third Heplisav-B Dose in Patients with Inflammatory Bowel Disease without Immunity Following Two-Dose Heplisav-B Vaccination.
     Am J Gastroenterol. 2024 May 8. doi: 10.14309/ajg.0000000000002863.
     PubMed     Abstract available
     
     
     
159. NARULA N, Hamam H, Peerani F, Bessissow T, et al
     Resolution of rectal bleeding by day 7 in acute severe ulcerative colitis is prognostic for post-discharge corticosteroid free clinical remission and endoscopic improvement.
     Am J Gastroenterol. 2024 May 8. doi: 10.14309/ajg.0000000000002860.
     PubMed     Abstract available
     
     
     
160. WU S, Liu Y, He Z, Bai Y, et al
     The Association Between Ultra-Processed Foods and Inflammatory Bowel Disease: Far More Complex Than Thought.
     Am J Gastroenterol. 2024 May 3. doi: 10.14309/ajg.0000000000002815.
     PubMed    
     
     
     
161. BERNSTEIN CN, Fisk JD, Dolovich C, Hitchon CA, et al
     Understanding Predictors of Fatigue Over Time in Persons With Inflammatory Bowel Disease: The Importance of Depressive and Anxiety Symptoms.
     Am J Gastroenterol. 2024;119:922-929.
     PubMed     Abstract available
     
     
     April 2024
162. ABREU MT, Kosinski LR
     How Did It Get So Difficult to Care for Patients With Inflammatory Bowel Disease?
     Am J Gastroenterol. 2024 Apr 30. doi: 10.14309/ajg.0000000000002794.
     PubMed    
     
     
     
163. STIDHAM RW, Enchakalody B, Wang SC, Su GL, et al
     Artificial Intelligence for Quantifying Cumulative Small Bowel Disease Severity on CT-Enterography in Crohn's Disease.
     Am J Gastroenterol. 2024 Apr 25. doi: 10.14309/ajg.0000000000002828.
     PubMed     Abstract available
     
     
     
164. MOHAMED MFH, Marino D, Elfert K, Beran A, et al
     Dye Chromoendoscopy Outperforms High-Definition White Light Endoscopy in Dysplasia Detection for Patients With Inflammatory Bowel Disease: An Updated Meta-Analysis of Randomized Controlled Trials.
     Am J Gastroenterol. 2024;119:719-726.
     PubMed     Abstract available
     
     
     March 2024
165. ALLEGRETTI JR, Axelrad J, Dalal RS, Kelly CR, et al
     Outcomes after Fecal Microbiota Transplantation in combination with Bezlotoxumab for Inflammatory Bowel Disease and Recurrent C . difficile Infection.
     Am J Gastroenterol. 2024 Mar 19. doi: 10.14309/ajg.0000000000002770.
     PubMed     Abstract available
     
     
     
166. KHAN N, Sundararajan R, Patel M, Trivedi C, et al
     Effectiveness Of Tofacitinib In Ulcerative Colitis Patients: A Nationwide Veterans Administration Cohort study.
     Am J Gastroenterol. 2024 Mar 14. doi: 10.14309/ajg.0000000000002761.
     PubMed     Abstract available
     
     
     
167. DALAL RS, Kallumkal G, Cabral HJ, Barnes EL, et al
     One-Year Comparative Effectiveness of Upadacitinib Versus Tofacitinib For Ulcerative Colitis: A Multicenter Cohort Study.
     Am J Gastroenterol. 2024 Mar 12. doi: 10.14309/ajg.0000000000002746.
     PubMed     Abstract available
     
     
     
168. EBACH DR, Jester TW, Galanko JA, Firestine AM, et al
     High Body Mass Index and Response to Anti-TNF Therapy in Pediatric Crohn Disease.
     Am J Gastroenterol. 2024 Mar 6. doi: 10.14309/ajg.0000000000002741.
     PubMed     Abstract available
     
     
     
169. CHUGH R, Long MD, Jiang Y, Weaver KN, et al
     Maternal and Neonatal Outcomes in Vedolizumab- and Ustekinumab-Exposed Pregnancies: Results From the PIANO Registry.
     Am J Gastroenterol. 2024;119:468-476.
     PubMed     Abstract available
     
     
     February 2024
170. ANDERSON KL, Anand R, Feuerstein JD
     Insurance Companies' Poor Adherence to Guidelines for Moderate to Severe Ulcerative Colitis/Crohn's Disease Management.
     Am J Gastroenterol. 2024 Feb 29. doi: 10.14309/ajg.0000000000002720.
     PubMed     Abstract available
     
     
     
171. FRIEDMAN S, Nielsen J, Qvist N, Knudsen T, et al
     Does surgery prior to pregnancy in women with inflammatory bowel disease increase the risk of adverse maternal and fetal outcomes? A Danish national cohort study.
     Am J Gastroenterol. 2024 Feb 20. doi: 10.14309/ajg.0000000000002732.
     PubMed     Abstract available
     
     
     
172. HERFARTH H
     Dysplasia Detection in Inflammatory Bowel Disease: An Updated Meta-Analysis With Effect.
     Am J Gastroenterol. 2024 Feb 16. doi: 10.14309/ajg.0000000000002658.
     PubMed    
     
     
     
173. SMITH RA, Desai A, Barnes EL, Hayney M, et al
     Patients with Inflammatory Bowel Disease are at Increased Risk for Hospitalization Due to Respiratory Syncytial Virus.
     Am J Gastroenterol. 2024 Feb 6. doi: 10.14309/ajg.0000000000002682.
     PubMed     Abstract available
     
     
     
174. SUN J, Yao J, Olen O, Halfvarson J, et al
     Long-term risk of myocarditis in patients with inflammatory bowel disease: a nationwide cohort study in Sweden.
     Am J Gastroenterol. 2024 Feb 5. doi: 10.14309/ajg.0000000000002701.
     PubMed     Abstract available
     
     
     
175. COHEN-MEKELBURG S, Valicevic A, Lin L, Saini SD, et al
     Inflammatory Bowel Disease Hospitalizations are Similar for Patients Receiving Tele-Visit Delivered Outpatient Care and Those Receiving Traditional In-Person Care.
     Am J Gastroenterol. 2024 Feb 5. doi: 10.14309/ajg.0000000000002703.
     PubMed     Abstract available
     
     
     
176. VAGIANOS K, Dolovich C, Witges K, Graff LA, et al
     Ultra-processed food, disease activity and inflammation in Ulcerative Colitis: The Manitoba Living with IBD Study.
     Am J Gastroenterol. 2024 Feb 2. doi: 10.14309/ajg.0000000000002667.
     PubMed     Abstract available
     
     
     
177. DRAGONI G, Innocenti T, Amiot A, Castiglione F, et al
     Rates of adverse events in patients with ulcerative colitis undergoing colectomy during treatment with tofacitinib vs biologics: a multicenter observational study.
     Am J Gastroenterol. 2024 Feb 2. doi: 10.14309/ajg.0000000000002676.
     PubMed     Abstract available
     
     
     
178. ANDREW B, Trinh S, Zhou A, Vasudevan A, et al
     Anal Cancer in Crohn's Disease: The Need to Optimize Treatment and Improve Surveillance.
     Am J Gastroenterol. 2024;119:390-391.
     PubMed    
     
     
     
179. COWARD S, Benchimol EI, Bernstein CN, Avina-Zubieta A, et al
     Forecasting the Incidence and Prevalence of Inflammatory Bowel Disease: A Canadian nationwide analysis.
     Am J Gastroenterol. 2024 Feb 1. doi: 10.14309/ajg.0000000000002687.
     PubMed     Abstract available
     
     
     
180. FAYE AS, Axelrad JE, Sun J, Halfvarson J, et al
     Atherosclerosis as a Risk Factor of Inflammatory Bowel Disease: A Population-Based Case-Control Study.
     Am J Gastroenterol. 2024;119:313-322.
     PubMed     Abstract available
     
     
     
181. DALAL RS, Norgard BM, Zegers FD, Kjeldsen J, et al
     Older Adult-Onset of Inflammatory Bowel Diseases Is Associated With Higher Utilization of Analgesics: A Nationwide Cohort Study.
     Am J Gastroenterol. 2024;119:323-330.
     PubMed     Abstract available
     
     
     
182. FEAGINS LA, Gold S, Steinlauf AF
     Overview of Biosimilars in Inflammatory Bowel Diseases.
     Am J Gastroenterol. 2024;119:229-232.
     PubMed    
     
     
     January 2024
183. CHETWOOD JD, Ko Y, Pudipeddi A, Kariyawasam V, et al
     Biological agents in the treatment of Crohn's disease: a propensity score-matched analysis from the prospective Persistence Australian National IBD Cohort (PANIC3) study.
     Am J Gastroenterol. 2024 Jan 26. doi: 10.14309/ajg.0000000000002679.
     PubMed     Abstract available
     
     
     
184. BERINSTEIN JA, Karl T, Patel A, Dolinger M, et al
     Effectiveness of Upadacitinib for Patients with Acute Severe Ulcerative Colitis: A Multi-Center Experience.
     Am J Gastroenterol. 2024 Jan 26. doi: 10.14309/ajg.0000000000002674.
     PubMed     Abstract available
     
     
     
185. TANDON P, Huang V, Feig DS, Saskin R, et al
     Recent Immigrants with Inflammatory Bowel Disease Have Significant Health-Care Utilization from Preconception to Postpartum: A Population Cohort Study.
     Am J Gastroenterol. 2024 Jan 23. doi: 10.14309/ajg.0000000000002668.
     PubMed     Abstract available
     
     
     
186. NARULA N, Wong ECL, Dulai PS, Marshall JK, et al
     Delayed Ustekinumab and Adalimumab Responders Have Similar Outcomes as Early Responders in Biologic-Naive Crohn's Disease.
     Am J Gastroenterol. 2024 Jan 18. doi: 10.14309/ajg.0000000000002654.
     PubMed     Abstract available
     
     
     
187. MA T, Han D, Sun M
     Acute Pancreatitis After Microscopic Colitis: Is It due to Drugs or Disease?
     Am J Gastroenterol. 2024;119:215-216.
     PubMed    
     
     
     
188. KIWAN W
     Continuing Medical Education Questions: January 2024.
     Am J Gastroenterol. 2024;119:29.
     PubMed     Abstract available
     
     
     December 2023
189. DOLINGER MT, Aronskyy I, Kellar A, Gao M, et al
     Determining the accuracy of intestinal ultrasound scores as a pre-screening tool in Crohn's disease clinical trials.
     Am J Gastroenterol. 2023 Dec 22. doi: 10.14309/ajg.0000000000002632.
     PubMed     Abstract available
     
     
     
190. SINGH A, Goyal MK, Midha V, Mahajan R, et al
     Tofacitinib in acute severe ulcerative colitis (TACOS): A randomized controlled trial: Tofacitinib in ASUC.
     Am J Gastroenterol. 2023 Dec 22. doi: 10.14309/ajg.0000000000002635.
     PubMed     Abstract available
     
     
     
191. AFIF W, Arasaradnam RP, Abreu MT, Danese S, et al
     Efficacy and Safety of Ustekinumab for Ulcerative Colitis Through 4 Years: Final Results of the UNIFI Long-term Maintenance Study.
     Am J Gastroenterol. 2023 Dec 14. doi: 10.14309/ajg.0000000000002621.
     PubMed     Abstract available
     
     
     
192. WEI L, Patil SA, Cross RK, Taubenslag KJ, et al
     Cystoid macular edema after initiation of ozanimod for ulcerative colitis.
     Am J Gastroenterol. 2023 Dec 12. doi: 10.14309/ajg.0000000000002622.
     PubMed    
     
     
     
193. BOUSVAROS A
     Collaborative Registries for Pediatric Crohn's Disease: A Leap Forward or More of the Same?
     Am J Gastroenterol. 2023 Dec 5. doi: 10.14309/ajg.0000000000002590.
     PubMed    
     
     
     
194. WEISS A, Barnes EL, Bewtra M
     A Practical Guide to the Use of Upadacitinib in Ulcerative Colitis and Crohn's Disease.
     Am J Gastroenterol. 2023 Dec 4. doi: 10.14309/ajg.0000000000002598.
     PubMed    
     
     
     
195. BOURGONJE AR, Mian P
     Identifying Phenotypic Determinants of Infliximab Target Concentrations in Inflammatory Bowel Disease: Toward Personalized Evidence-Based Dosing Regimens.
     Am J Gastroenterol. 2023;118:2308-2309.
     PubMed    
     
     
     
196. DULANEY DT
     Continuing Medical Education Questions: December 2023.
     Am J Gastroenterol. 2023;118:2122.
     PubMed     Abstract available
     
     
     November 2023
197. KAYAL M, Deepak P, Beniwal-Patel P, Raffals L, et al
     Changes in Therapy Are Not Associated with Increased Remission in Patients with Crohn's Disease of the Pouch.
     Am J Gastroenterol. 2023 Nov 17. doi: 10.14309/ajg.0000000000002599.
     PubMed     Abstract available
     
     
     
198. ANDREW B, Vasudevan A, Srinivasan A
     The Role of Intestinal Ultrasound During Pregnancy in Patients With Inflammatory Bowel Disease.
     Am J Gastroenterol. 2023;118:2096-2097.
     PubMed    
     
     
     
199. BARNES EL, Desai A, Kochhar GS
     The Comparative Effectiveness of Ciprofloxacin and Metronidazole for an Initial Episode of Pouchitis: A Propensity-Matched Study.
     Am J Gastroenterol. 2023;118:1989-1996.
     PubMed     Abstract available
     
     
     
200. SANTIAGO P, Barnes EL, Raffals LE
     Classification and Management of Disorders of the J Pouch.
     Am J Gastroenterol. 2023;118:1931-1939.
     PubMed     Abstract available
     
     
     
201. SACHDEVA K, Agarwal S, Kumar P, Mathew D, et al
     Revised Algorithmic Approach to Differentiate Between Nonspecific and Specific Etiologies of Chronic Terminal Ileitis.
     Am J Gastroenterol. 2023;118:2052-2060.
     PubMed     Abstract available
     
     
     
202. YARUR AJ, Abreu MT, Deepak P, Beniwal-Patel P, et al
     Patients With Inflammatory Bowel Diseases and Higher Visceral Adipose Tissue Burden May Benefit From Higher Infliximab Concentrations to Achieve Remission.
     Am J Gastroenterol. 2023;118:2005-2013.
     PubMed     Abstract available
     
     
     
203. MOHAN BP, Fatima N, Khan SR, Kassab L, et al
     Early Remission With Induction Therapy Predicts Long-Term Remission in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis.
     Am J Gastroenterol. 2023;118:2084-2087.
     PubMed    
     
     
     
204. KOCHAR B, Mao EJ, Shah SA
     Optimal Dysplasia Detection and Management in IBD: Now and in the Future.
     Am J Gastroenterol. 2023;118:1905-1908.
     PubMed    
     
     
     
205. DUNLEAVY KA, Cross RK, Raffals LE
     Causes, Diagnostic Testing, and Treatment of Residual Symptoms in Patients With IBD With Quiescent Disease.
     Am J Gastroenterol. 2023;118:1909-1914.
     PubMed    
     
     
     October 2023
206. GENERE JR, Ballard DH, Deepak P
     Three-Dimensional Modeling to Guide Interventional Endoscopy in Fibrostenotic Crohn's Disease.
     Am J Gastroenterol. 2023 Oct 13. doi: 10.14309/ajg.0000000000002558.
     PubMed    
     
     
     
207. PHAM JT, Ghusn W, Acosta A, Loftus EV Jr, et al
     Effectiveness and Safety of Antiobesity Medications in Patients With Obesity and Inflammatory Bowel Disease.
     Am J Gastroenterol. 2023 Oct 9. doi: 10.14309/ajg.0000000000002490.
     PubMed     Abstract available
     
     
     
208. DEBRUYN JC, Huynh HQ, Griffiths AM, Jacobson K, et al
     ADALIMUMAB VERSUS INFLIXIMAB IN LUMINAL PEDIATRIC CROHN'S DISEASE: COMPARABLE OUTCOMES IN A PROSPECTIVE MULTICENTER COHORT STUDY.
     Am J Gastroenterol. 2023 Oct 3. doi: 10.14309/ajg.0000000000002552.
     PubMed     Abstract available
     
     
     
209. SHUJA A
     Continuing Medical Education Questions: October 2023.
     Am J Gastroenterol. 2023;118:1742.
     PubMed     Abstract available
     
     
     
210. COELHO-PRABHU N, Lewis JD
     Update on Endoscopic Dysplasia Surveillance in Inflammatory Bowel Disease.
     Am J Gastroenterol. 2023;118:1748-1755.
     PubMed     Abstract available
     
     
     September 2023
211. ALSOUD D, Ho J, Sabino J, Ferrante M, et al
     Utility of the Serum-Based Endoscopic Healing Index in Monitoring Therapeutic Response in Ulcerative Colitis.
     Am J Gastroenterol. 2023 Sep 27. doi: 10.14309/ajg.0000000000002518.
     PubMed     Abstract available
     
     
     
212. BAK MTJ, Huinink STB, Erler NS, Bodelier AGL, et al
     Prognostic value of the modified Rutgeerts' score for long-term outcomes after primary ileocecal resection in Crohn's disease.
     Am J Gastroenterol. 2023 Sep 22. doi: 10.14309/ajg.0000000000002509.
     PubMed     Abstract available
     
     
     
213. CAIRNS CA, Cross RK, Khambaty M, Bafford AC, et al
     Monitoring Patients with Inflammatory Bowel Disease at High Risk of Anal Cancer.
     Am J Gastroenterol. 2023 Sep 18. doi: 10.14309/ajg.0000000000002503.
     PubMed     Abstract available
     
     
     
214. SANTIAGO P, Coelho-Prabhu N, Lennon R, Rui S, et al
     Baseline Clinical Factors are Associated with Risk of Complications in Crohn's Disease: Appraisal of the AGA Clinical Care Pathway.
     Am J Gastroenterol. 2023 Sep 15. doi: 10.14309/ajg.0000000000002498.
     PubMed     Abstract available
     
     
     
215. WILKERSON RC
     Continuing Medical Education Questions: September 2023.
     Am J Gastroenterol. 2023;118:1543.
     PubMed     Abstract available
     
     
     
216. KAHN-BOESEL O, Cautha S, Ufere NN, Ananthakrishnan AN, et al
     A Narrative Review of Financial Burden, Distress, and Toxicity of Inflammatory Bowel Diseases in the United States.
     Am J Gastroenterol. 2023;118:1545-1553.
     PubMed     Abstract available
     
     
     August 2023
217. CHANG S, Murphy M, Malter L
     A Review of Available Medical Therapies to Treat Moderate to Severe Inflammatory Bowel Disease in 2023.
     Am J Gastroenterol. 2023 Aug 24. doi: 10.14309/ajg.0000000000002485.
     PubMed     Abstract available
     
     
     
218. LEVARTOVSKY A, Ben-Horin S, Kopylov U, Klang E, et al
     Towards AI-Augmented Clinical Decision Making: An Examination of ChatGPT's Utility in Acute Ulcerative Colitis Presentations.
     Am J Gastroenterol. 2023 Aug 23. doi: 10.14309/ajg.0000000000002483.
     PubMed     Abstract available
     
     
     
219. YANG Y, Ludvigsson JF, Olen O, Sjolander A, et al
     Absolute and relative risks of kidney and urological complications in patients with inflammatory bowel disease.
     Am J Gastroenterol. 2023 Aug 10. doi: 10.14309/ajg.0000000000002473.
     PubMed     Abstract available
     
     
     
220. RAMPERTAB SD
     Continuing Medical Education Questions: August 2023.
     Am J Gastroenterol. 2023;118:1321.
     PubMed     Abstract available
     
     
     
221. BOPARAI ES, Lee JK, Zhu S, Shirazi A, et al
     The Contemporary Probability of Occult Colorectal Cancer in Patients With Colitis-Related Dysplasia Undergoing Colectomy.
     Am J Gastroenterol. 2023;118:1453-1456.
     PubMed     Abstract available
     
     
     July 2023
222. DUBINSKY M, Bleakman AP, Panaccione R, Hibi T, et al
     Bowel Urgency in Ulcerative Colitis: Current Perspectives and Future Directions.
     Am J Gastroenterol. 2023 Jul 12. doi: 10.14309/ajg.0000000000002404.
     PubMed     Abstract available
     
     
     
223. FERNANDEZ C, Gajic Z, Esen E, Remzi F, et al
     Preoperative Risk Factors for Adverse Events in Adults Undergoing Bowel Resection for Inflammatory Bowel Disease: 15-Year Assessment of ACS-NSQIP.
     Am J Gastroenterol. 2023 Jul 7. doi: 10.14309/ajg.0000000000002395.
     PubMed     Abstract available
     
     
     
224. BONFILS L, Sandri AK, Poulsen GJ, Agrawal M, et al
     Medication-wide study: Exploring medication use ten years prior to a diagnosis of inflammatory bowel disease.
     Am J Gastroenterol. 2023 Jul 7. doi: 10.14309/ajg.0000000000002399.
     PubMed     Abstract available
     
     
     
225. BACHOUR SP, Khan MZ, Shah RS, Joseph A, et al
     Anastomotic configuration and temporary diverting ileostomy do not increase risk for anastomotic stricture in postoperative Crohn's disease.
     Am J Gastroenterol. 2023 Jul 7. doi: 10.14309/ajg.0000000000002393.
     PubMed     Abstract available
     
     
     
226. VUYYURU SK, Archer M, Nguyen TM, Beaton M, et al
     Long washout periods between biologics for inflammatory bowel disease clinical trials are unnecessary: A Canadian retrospective cohort study.
     Am J Gastroenterol. 2023 Jul 6. doi: 10.14309/ajg.0000000000002398.
     PubMed     Abstract available
     
     
     
227. BALI AS, Hashash JG, Picco MF, Kinnucan JA, et al
     Electronic Health Record Burden Among Gastroenterology Providers Associated With Subspecialty and Training.
     Am J Gastroenterol. 2023;118:1282-1284.
     PubMed     Abstract available
     
     
     June 2023
228. HU FH, Chen HL
     Low Risk of Lymphoma in Pediatric Patients Treated for Inflammatory Bowel Disease: Need More Evidence.
     Am J Gastroenterol. 2023;118:1101-1102.
     PubMed    
     
     
     
229. DULANEY DT
     Continuing Medical Education Questions: June 2023.
     Am J Gastroenterol. 2023;118:935.
     PubMed     Abstract available
     
     
     
230. DULANEY DT
     Continuing Medical Education Questions: June 2023.
     Am J Gastroenterol. 2023;118:935.
     PubMed     Abstract available
     
     
     May 2023
231. MARKOVINOVIC A, Quan J, Herauf M, Hracs L, et al
     Adverse Events & Serological Responses Following SARS-CoV-2 Vaccination in Individuals with Inflammatory Bowel Disease.
     Am J Gastroenterol. 2023 May 22. doi: 10.14309/ajg.0000000000002337.
     PubMed     Abstract available
     
     
     
232. BARNES EL, Zhang X, Long MD, Herfarth HH, et al
     Rate of Colectomy Increases within Twelve Months of Sequential Therapy for Ulcerative Colitis.
     Am J Gastroenterol. 2023 May 22. doi: 10.14309/ajg.0000000000002331.
     PubMed     Abstract available
     
     
     
233. PARIAN AM, Obi M, Fleshner P, Schwartz DA, et al
     Management of Perianal Crohn's Disease - AJG.
     Am J Gastroenterol. 2023 May 19. doi: 10.14309/ajg.0000000000002326.
     PubMed     Abstract available
     
     
     
234. LEY D, Leroyer A, Dupont C, Sarter H, et al
     New therapeutic strategies are associated with a significant decrease in colectomy rate in pediatric ulcerative colitis.
     Am J Gastroenterol. 2023 May 4. doi: 10.14309/ajg.0000000000002316.
     PubMed     Abstract available
     
     
     
235. GOLDOWSKY A, Billings W, Kickel A, Charabaty A, et al
     @MondayNightIBD and the Expanding Gastroenterology Twitterverse: A Study on Continuing Medical Education on #GITwitter.
     Am J Gastroenterol. 2023;118:855-860.
     PubMed     Abstract available
     
     
     April 2023
236. MORTREUX P, Leroyer A, Dupont C, Ley D, et al
     Natural history of anal ulcerations in pediatric-onset Crohn's disease: long-term follow-up of a population-based study.
     Am J Gastroenterol. 2023 Apr 25. doi: 10.14309/ajg.0000000000002301.
     PubMed     Abstract available
     
     
     
237. COHEN-MEKELBURG S, Van T, Berinstein JA, Yu X, et al
     Characteristics of Facilities with Early and Rapid Ustekinumab Adoption for Patients with Inflammatory Bowel Disease.
     Am J Gastroenterol. 2023 Apr 25. doi: 10.14309/ajg.0000000000002304.
     PubMed     Abstract available
     
     
     
238. YANG JY, Lund JL, Funk MJ, Hudgens MG, et al
     Utilization of Treat-to-Target Monitoring Colonoscopy after Treatment Initiation in the US-Based Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease (SPARC IBD).
     Am J Gastroenterol. 2023 Apr 13. doi: 10.14309/ajg.0000000000002294.
     PubMed     Abstract available
     
     
     
239. MARCHEGIANI F, Laurent A, de'Angelis N
     Abdominal mass in a patient with autoimmune hepatitis, ulcerative colitis and BRCA family history - not always what you expect.
     Am J Gastroenterol. 2023 Apr 11. doi: 10.14309/ajg.0000000000002284.
     PubMed    
     
     
     March 2023
240. AHUJA D, Murad MH, Ma C, Jairath V, et al
     Comparative Speed of Early Symptomatic Remission with Advanced Therapies for Moderate-Severe Ulcerative Colitis: A Systematic Review and Network Meta-Analysis.
     Am J Gastroenterol. 2023 Mar 29. doi: 10.14309/ajg.0000000000002263.
     PubMed     Abstract available
     
     
     
241. OGINO T, Mizushima T, Fujii M, Sekido Y, et al
     Crohn's disease-associated anorectal cancer has a poor prognosis with high local recurrence: a subanalysis of the Nationwide Japanese Study.
     Am J Gastroenterol. 2023 Mar 28. doi: 10.14309/ajg.0000000000002269.
     PubMed     Abstract available
     
     
     
242. ZORZI F, Rubin DT, Cleveland NK, Monteleone G, et al
     Ultrasonographic Transmural healing in Crohn's disease.
     Am J Gastroenterol. 2023 Mar 28. doi: 10.14309/ajg.0000000000002265.
     PubMed     Abstract available
     
     
     
243. FINE LS, Zhu S, Shirazi A, Lee JK, et al
     Increased Risk of Hospitalization, Surgery and Venous Thromboembolism Among Patients with Inflammatory Bowel Disease and Malnutrition in a Large, Community-Based Healthcare System.
     Am J Gastroenterol. 2023 Mar 9. doi: 10.14309/ajg.0000000000002241.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum